Wnt Signaling in Human Type II Diabetes
Author Information
Author(s): Lee Seung-Hee, Demeterco Carla, Geron Ifat, Abrahamsson Annelie, Levine Fred, Itkin-Ansari Pamela
Primary Institution: Burnham Institute for Medical Research
Hypothesis
The study investigates the role of Wnt signaling in the pathogenesis of type II diabetes.
Conclusion
Wnt signaling components are upregulated in the islets of type II diabetic patients, suggesting a dynamic role in diabetes pathogenesis.
Supporting Evidence
- TCF7L2 and other Wnt signaling components were found to be upregulated in islets from type II diabetic patients.
- β-catenin was low or absent in normal human islets but highly expressed in islets from type II diabetic patients.
- c-myc and cyclinD1, important regulators of cell proliferation, were also upregulated in type II diabetic islets.
Takeaway
This study found that certain signals in the pancreas are different in people with type II diabetes, which might help us find new ways to treat the disease.
Methodology
The study examined pancreatic tissue from 5 nondiabetic and 9 type II diabetic individuals, using immunohistochemistry and Western blotting to analyze Wnt signaling components.
Potential Biases
Potential bias due to the small sample size and the specific population studied.
Limitations
The study is based on a limited number of human samples and may not represent all cases of type II diabetes.
Participant Demographics
5 nondiabetic individuals and 9 type II diabetic individuals.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website